Celltech Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
Celltech Pharmaceuticals, Inc. holds 25 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SEMPREX. The owner is based in Rochester, NY.
755 Jefferson Road
Rochester, NY 14623
Showing of trademarks Trademarks
Trademark Classifications
Celltech Pharmaceuticals, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Celltech Pharmaceuticals, Inc. have?
Celltech Pharmaceuticals, Inc. has 25 U.S. trademarks filed with the USPTO. Of these, 1 registered, 21 abandoned, 3 cancelled.
What trademark classes does Celltech Pharmaceuticals, Inc. file in?
Celltech Pharmaceuticals, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 16 (Paper Goods), Class 35 (Advertising & Business), Class 20 (Furniture). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Celltech Pharmaceuticals, Inc.'s most well-known trademarks?
Celltech Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as SEMPREX. These are among 1 currently registered trademark in the portfolio.
What is Celltech Pharmaceuticals, Inc.'s trademark registration success rate?
Celltech Pharmaceuticals, Inc. has a 4% trademark registration rate, with 1 out of 25 resolved applications resulting in successful registration. Currently, 0 applications are pending review.